Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03131999 · ClinicalTrials.gov registry record · Phase 1
LAM Pilot Study With Imatinib Mesylate
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT03131999: Completed Phase 1 study, sponsored by Medical University of South Carolina.
NCT03131999 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 18 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03131999, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is a phase 1 clinical trial comparing imatinib mesylate to placebo for individuals with lymphangioleiomyomatosis (LAM).
Primary Outcome
Change in the square root of the intrasubject plasma VEGF-D
Interventions
- DRUG Imatinib Mesylate 400Mg Capsule
- DRUG Placebo - Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-01-23 |
| Est. Completion | 2019-03-07 |
| Phase | Phase 1 |
What the finished NCT03131999 record still lists
NCT03131999 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 2 interventions - of which Imatinib Mesylate 400Mg Capsule is the first listed.
NCT03131999 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03131999 about?
NCT03131999 is a clinical study titled "LAM Pilot Study With Imatinib Mesylate". This is a phase 1 clinical trial comparing imatinib mesylate to placebo for individuals with lymphangioleiomyomatosis (LAM).
What is the current status of trial NCT03131999?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2018-01-23. Estimated completion is 2019-03-07.
What interventions are being tested in trial NCT03131999?
The interventions under investigation include: Imatinib Mesylate 400Mg Capsule (DRUG), Placebo - Capsule (DRUG).
Who is sponsoring clinical trial NCT03131999?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03131999's enrollment target sits among peer trials
18 1720th of 2000 higher than 216 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI